Monsanto Co. (NYSE:MON) – Jefferies Group issued their Q1 2017 earnings per share (EPS) estimates for shares of Monsanto in a research note issued on Thursday. Jefferies Group analyst L. Alexander anticipates that the brokerage will earn $0.04 per share for the quarter. Jefferies Group has a “Buy” rating on the stock. Jefferies Group also issued estimates for Monsanto’s Q2 2017 earnings at $2.47 EPS, Q3 2017 earnings at $2.04 EPS, Q4 2017 earnings at $0.09 EPS and FY2020 earnings at $7.35 EPS.

Other analysts have also recently issued research reports about the company. Credit Agricole SA reissued a “buy” rating on shares of Monsanto in a research report on Saturday, July 2nd. Vetr cut Monsanto from a “strong-buy” rating to a “buy” rating and set a $116.47 price target for the company. in a research report on Thursday, July 14th. Deutsche Bank AG reaffirmed a “buy” rating and set a $118.00 price target on shares of Monsanto in a research report on Thursday, June 30th. Argus reaffirmed a “buy” rating and set a $128.00 price target (up previously from $111.00) on shares of Monsanto in a research report on Wednesday, June 15th. Finally, Monness Crespi & Hardt raised Monsanto from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $106.93 to $130.00 in a research report on Monday, August 8th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $114.67.

Earnings History and Estimates for Monsanto (NYSE:MON)

Shares of Monsanto (NYSE:MON) opened at 103.36 on Friday. The company’s 50 day moving average price is $104.86 and its 200 day moving average price is $101.43. Monsanto has a 52-week low of $83.73 and a 52-week high of $114.26. The stock has a market cap of $45.23 billion, a PE ratio of 45.49 and a beta of 1.19.

Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm earned $2.56 billion during the quarter, compared to analysts’ expectations of $2.38 billion. During the same quarter last year, the business posted ($0.19) earnings per share. The firm’s revenue was up 8.8% on a year-over-year basis.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Advisory Services Network LLC boosted its position in Monsanto by 688.3% in the third quarter. Advisory Services Network LLC now owns 7,457 shares of the company’s stock worth $762,000 after buying an additional 6,511 shares in the last quarter. Franklin Street Advisors Inc. NC boosted its position in Monsanto by 24.7% in the third quarter. Franklin Street Advisors Inc. NC now owns 62,980 shares of the company’s stock worth $6,437,000 after buying an additional 12,475 shares in the last quarter. Acropolis Investment Management LLC boosted its position in Monsanto by 4.0% in the third quarter. Acropolis Investment Management LLC now owns 3,319 shares of the company’s stock worth $339,000 after buying an additional 127 shares in the last quarter. Burke & Herbert Bank & Trust Co. boosted its position in Monsanto by 5.5% in the third quarter. Burke & Herbert Bank & Trust Co. now owns 2,606 shares of the company’s stock worth $266,000 after buying an additional 137 shares in the last quarter. Finally, BNP Paribas Arbitrage SA boosted its position in Monsanto by 5.2% in the third quarter. BNP Paribas Arbitrage SA now owns 308,850 shares of the company’s stock worth $31,564,000 after buying an additional 15,128 shares in the last quarter. Hedge funds and other institutional investors own 79.02% of the company’s stock.

In related news, COO Brett D. Begemann sold 27,980 shares of the company’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total value of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares in the company, valued at $10,618,977.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Michael K. Stern sold 12,797 shares of the company’s stock in a transaction that occurred on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total value of $1,302,350.69. Following the completion of the transaction, the chief executive officer now owns 21,583 shares in the company, valued at $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is owned by insiders.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be given a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.09%. Monsanto’s dividend payout ratio (DPR) is presently 71.05%.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.